Pacific Biosciences Of California (PACB) Deferred Taxes (2021 - 2025)

Pacific Biosciences Of California's Deferred Taxes history runs 4 years deep, the most recent figure standing at -$546000.0 for Q1 2025.

• On a quarterly basis, Deferred Taxes changed N/A year-over-year to -$546000.0 in Q1 2025; TTM through Dec 2025 was -$546000.0, a 166.34% decrease from a year earlier, with the FY2025 full-year figure at -$546000.0, down 166.34% from the prior year.
• Deferred Taxes slipped to -$546000.0 in Q1 2025 per PACB's latest filing, from -$205000.0 in the prior quarter.
• Across five years, Deferred Taxes topped out at $1.2 million in Q4 2021 and bottomed at -$718000.0 in Q4 2023.
• The 4-year median for Deferred Taxes is -$375500.0 (2024), against an average of -$73500.0.
• Biggest YoY gain for Deferred Taxes was 71.45% in 2024; the steepest drop was 71.45% in 2024.
• Year by year, Deferred Taxes stood at $1.2 million in 2021, then plunged by 161.11% to -$718000.0 in 2023, then surged by 71.45% to -$205000.0 in 2024, then plunged by 166.34% to -$546000.0 in 2025.
• Per Business Quant, the three latest PACB Deferred Taxes figures stand at -$546000.0 (Q1 2025), -$205000.0 (Q4 2024), and -$718000.0 (Q4 2023).